Friday, April 26, 2024 11:33:54 AM
Greetings HHSE Friends - here is a quick summary of key items as of Friday, April 26, 2024:
1). OTC FILINGS - A second round of formatting and disclosure revisions were posted last night for the year-end report (12-31-2023); once this filing is approved, the company will be restored to “current” reporting status.
2). Upon restoration to “current status” - we will be able to file the annual attorney opinion letter for further compliance.
3). OTC QB application is ready to file as soon as the audit opinion letter is provided. Audited financials for 12-31-2023 will also be filed to SEC Edgar, to achieve fully reporting compliance.
4). Final prep is underway for CANNES meetings for international sales & licensing. HHSE will be offering seven titles… NOT including a new project - a $10-mm financed action adventure feature to shoot later this year in Hungary. Excited to be working with ADRIAN PAUL (“Highlander”) on this one, and with his FormaFilmz team.
Link to Blog --> $HHSE Filings & General Update
Link to OTC Filing --> OTC Filing - $HHSE Annual Report 2023
MUCH MORE TO FOLLOW!!
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM